Global Acute Sinusitis Market Size, Share, Forecast Report, 2020-2027

Also known as acute rhinosinusitis, acute sinusitis is a short-term inflammation of the membranes lining the nose and surrounding sinuses. There are various causes of acute sinusitis such as intranasal allergies, hay fever, nasal polyps, infected adenoids, deviated nasal septum, and cystic fibrosis. Symptoms of acute sinusitis include nasal congestion, sore throat, cough, headache, bad breath, pressure, or tenderness behind your eyes, nose, cheeks, or forehead, toothache, and many others. Diagnosis of the disease can be made using various tests such as nasal endoscopy, imaging tests such as MRI and CT scan, and allergy testing. The treatment of acute sinusitis includes the use of the saline nasal spray, nasal corticosteroids, decongestants, OTC pain relievers, allergy shots, antibiotics, and others. As per the American Academy of Otolaryngology, acute sinusitis is common and mainly affects around 1 in 8 adults per year.

The increasing number of patients suffering from acute sinusitis, rising number of diagnostic tests, and increasing number of players manufacturing drugs for the treatment of acute sinusitis are the major factors contributing to the growth of the market. Furthermore, the increasing use of medical devices for diagnosis and treatment of diseases and the use of various medications for the treatment such as nasal sprays, nasal corticosteroids, and decongestants are also expected to accelerate the growth of the market during the forecast period. However, unawareness about sinusitis, its diagnosis, and treatment also fuel the growth of the market.

Global acute sinusitis market is expected to grow at a CAGR of 6.2% during the forecast period.

Segments

The global acute sinusitis market is segmented on the basis of diagnosis, treatment, and end-user.

On the basis of diagnosis, the market is segmented into nasal endoscopy, imaging tests, laboratory tests, and allergy testing. Imaging tests are further segmented into CT scan and MRI.

On the basis of treatment, the market is segmented into saline nasal spray, nasal corticosteroids, decongestant, OTC pain relievers, allergy shots, antibiotics, and others.

On the basis of end-user, the market is segmented into hospitals and clinics, research centers, and others.
Key Players in the Global Acute Sinusitis Market

Some of the key players in this market are Sanofi (France), Abbott (U.S.), Bayer AG (U.S.), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), Merck & Co, Inc. (U.S.), AstraZeneca Plc (U.K), Reddy’s Lab (India), Novartis AG (Germany), and others.